Table of Contents Table of Contents
Previous Page  207 / 330 Next Page
Information
Show Menu
Previous Page 207 / 330 Next Page
Page Background

207

19–22 APRIL, 2017, BARCELONA, SPAIN

17:14–17:17

S19-6 (PP)

CORRELATION OF CLINICAL COURSE TO ANTIBIOTIC

SUSCEPTIBILITY RESULTS OF EXTENDED SPECTRUM

BETA-LACTAMASE OF GRAM NEGATIVE BACTERIA

IN PEDIATRIC UTI PATIENTS

Chang-Hee HAN

1

, Sang-Rak BAE

1

, Jae Shin PARK

2

and Jun-Se JUNG

1

1) Uijeongbu St. Mary’s Hospital, Urology, Uijeongbu, REPUBLIC OF KOREA - 2) Daegu Catholic University Medical

Center, Department of Urology, Daegu, REPUBLIC OF KOREA

PURPOSE

This study is aimed to identify the effect of disease progression in febrile pediatric UTI patients ad-

mitted for treatment in correlation to antibiotics susceptibility of extended spectrum beta-lactamase

positive bacteria.

MATERIAL AND METHODS

In order to find correlation between antibiotic susceptibility results and clinical course a retrospective

analysis using medical records was done in 1343 febrile pediatric UTI patients admitted to the

hospital for antibiotic treatment from January 2010 to April 2015, with outcomes positive to gram

negative bacteria in urine culture. Blood tests, urine analysis, urine culture, antibiotic susceptibility

tests were identified, along with the initial antibiotics, changes in antibiotics, negative conversion

period, antibiotics susceptibility results in relation to negative conversion period, and vital signs with

other characteristics were analyzed.

RESULTS

Out of the 1343 patients admitted for febrile UTI, 67 patients were identified with ESBL positive

bacteria in their urine culture. In which 35 patients were male and 32 were female. Of the 67 patients

the number resistant to initial antibiotics were 10(14.9%). Changes in antibiotics were made in

only 2 cases, the other 8 cases did not need changes in antibiotics and negative conversion was

identified on the 2

nd

hospital date. Aminoglycoside was used in initial treatment for 63 patients out

of 67 and negative conversion was identified in all patients without using meropenem. The mean

negative conversion period was 2.25 days. Only 5 cases(7.5%) in total changed antibiotics to

meropenem or tazocin, and resulted in negative conversion in urine culture after 1 day of use.

CONCLUSIONS

Unlike adult patients, ESBL positive pediatric UTI patients showed susceptibility to aminoglyco-

sides. In cases with difficulty in identifying antibiotics susceptibility, aminoglycoside is a good choice

for initial antibiotics without the use of carbapenem or meropenem for effective treatment results.